semaglutide price Weight-loss jab could be made for $3 a month, study finds | Global health Novo cuts GLP-1 prices 70%,

Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model

In the field of drug development, DPP-IV inhibitors have opened up numerous opportunities for leveraging this target to generate compounds as hypoglycemic agents by regulating incretin activity and subsequently decreasing blood glucose levels

What happens to the body when you stop taking weight-loss medications GLP-1 receptor agonists are a class of weight-loss medications designed to imitate their namesake hormone, glucagon-like peptide-1

Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus